Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy-Reference-Cited by-同舟云学术

Immunologic Monitoring of Cellular Immune Responses in Cancer Vaccine Therapy

Published:2011 Issue: Volume:2011 Page:1-3
ISSN:1110-7243
Container-title:Journal of Biomedicine and Biotechnology
language:en
Short-container-title:Journal of Biomedicine and Biotechnology

Author:

Whiteside Theresa L.¹,Gulley James L.²,Clay Timothy M.³,Tsang Kwong Yok²

Affiliation:

1. Department of Pathology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213-1863, USA

2. Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA

3. Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA

Publisher

Hindawi Limited

Subject

Health, Toxicology and Mutagenesis,Genetics,Molecular Biology,Molecular Medicine,General Medicine,Biotechnology

Link

http://downloads.hindawi.com/journals/bmri/2011/370374.pdf

Reference9 articles.

1. Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination

2. Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

3. Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

4. Immunosuppressive CD14+ HLA-DRlow/− monocytes in prostate cancer

5. Significance of Macrophage Chemoattractant Protein-1 Expression and Macrophage Infiltration in Squamous Cell Carcinoma of the Esophagusa

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised;Frontiers in Medicine;2020-04-02

2. Obstacles in the Development of Therapeutic Cancer Vaccines;Vaccines for Cancer Immunotherapy;2019

3. Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy;Cytotherapy;2018-05

4. Toll-Like Receptors in Alzheimer’s Disease: A Therapeutic Perspective;CNS & Neurological Disorders - Drug Targets;2014-12-12

5. Peptide Vaccines for Treatment of Colon Cancer: Have We Made Progress?;Current Colorectal Cancer Reports;2014-09-17